Papers

1

Total Citations

31

H-Index

1

About

Raymond Evers is a leading figure in drug transport and pharmacokinetics, with a focus on the role of ATP-binding cassette (ABC) transporters in drug disposition and resistance. His work has been instrumental in understanding how P-glycoprotein (P-gp) influences drug absorption, distribution, and elimination, directly impacting drug development and clinical safety. In his highly cited 2012 study, Evers developed and validated a robust method for determining P-gp–drug interactions using both reconstituted P-gp in liposomal systems and LLC-MDR1 polarized cell monolayers. This work provided a critical framework for predicting transporter-mediated drug-drug interactions, a key requirement in regulatory submissions. With over 31 citations, this paper exemplifies his contribution to refining in vitro models that bridge mechanistic biology and applied pharmacology. Evers’ research has shaped how pharmaceutical scientists evaluate candidate drugs, ensuring safer and more effective therapies. His achievements underscore a career dedicated to translating transporter biology into practical, high-impact tools for drug discovery and development.

Research Focus

Key Achievements

1
H-Index
1
Papers
31
Total Citations
31
Avg Citations/Paper
🏆 Most Cited Paper
Determining P-glycoprotein–drug interactions: Evaluation of reconstituted P-glycoprotein in a liposomal system and LLC-MDR1 polarized cell monolayers
31 citations · 2012
📈 Most Prolific Year: 2012 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Merck & Co., Inc., Rahway, NJ, USA (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago